Home/Filings/4/0001104659-26-001471
4//SEC Filing

MOLINA ARTURO MD 4

Accession 0001104659-26-001471

CIK 0001377121other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 7:35 PM ET

Size

7.6 KB

Accession

0001104659-26-001471

Insider Transaction Report

Form 4
Period: 2026-01-02
MOLINA ARTURO MD
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2026-01-02+25,600106,780 total
  • Award

    Stock Option (right to buy)

    2026-01-02+32,00032,000 total
    Exercise: $87.18Exp: 2036-01-02Common Stock (32,000 underlying)
Footnotes (2)
  • [F1]Represents grant of restricted stock units payable solely in common stock that will vest in four equal annual installments on January 15, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
  • [F2]The stock option vests in 48 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother

Related Parties

1
  • filerCIK 0001398940

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:35 PM ET
Size
7.6 KB